Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bio-Path Holdings (NQ: BPTH )

0.5206 -0.0185 (-3.43%)
Streaming Delayed Price Updated: 3:52 PM EST, Dec 8, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Bio-Path Holdings

< Previous 1 2 3 4 Next >
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Bio-Path Releases Early Cut Data From Mid-Stage Prexigebersen Trial In Acute Myeloid Leukemia
Bio-Path Holdings Inc (NASDAQ: BPTH) reported interim data from Stage 2 of the company's Phase 2 study of prexigebersen in combination with decitabine and venetoclax for  
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
  Wednesday saw 59 companies set new 52-week lows. 
Via Benzinga
Bio-Path Holdings Earnings Preview
Via Benzinga
A Preview Of Bio-Path Holdings's Earnings
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
  On Tuesday, 56 companies set new 52-week lows. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
  On Monday morning, 70 companies achieved new lows for the year. 
Via Benzinga
Why Is FibroGen (FGEN) Stock Down 81% Today?
FibroGen (FGEN) stock is heading lower on Monday after the company's Phase 3 clinical trial failed to meet its primary endpoint. 
Via InvestorPlace
Why Is MoonLake Immunotherapeutics (MLTX) Stock Up 93% Today?
MoonLake Immunotherapeutics (MLTX) stock is taking off on Monday after reporting positive results from a Phase 2 clinical trial. 
Via InvestorPlace
Why Carnival Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers Benitec Biopharma Inc. (NASDAQ: BNTC) climbed 104% to $0.4050 after the company announced it received FDA clearance of the IND for BB-301 for the treatment of Oculopharyngeal Muscular... 
Via Benzinga
Why Is Bio-Path (BPTH) Stock Down 12% Today?
Bio-Path (BPTH) stock is sliding lower on Monday after the biotechnology company announced a proposed public share offering. 
Via InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
It's time to start off the week right with a breakdown of the biggest pre-market stock movers worth watching on Monday morning! 
Via InvestorPlace
Earnings Scheduled For May 12, 2023
Companies Reporting Before The Bell • Honda Motor Co (NYSE:HMC) is expected to report earnings for its fourth quarter. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Bio-Path Holdings Q3 2022 Earnings Conference Call On November 15, 2022 At 08:30 AM ET
Bio-Path Holdings (NASDAQ:BPTH) will host a conference call at 08:30 AM ET on November 15, 2022, to discuss Q3 2022 earnings results. How to Attend Bio-Path Holdings (BPTH) Conference Call Follow this... 
Via Benzinga
Analyzing Bio-Path Holdings's Short Interest
Bio-Path Holdings's (NASDAQ:BPTH) short percent of float has fallen 10.42% since its last report. The company recently reported that it has 34 thousand shares sold short, which is 0.43% of all regular... 
Via Benzinga
Why Huadi International Group Shares Dipped Around 91%; Here Are 79 Biggest Movers From Yesterday
Gainers 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers 
Via Benzinga
Bio-Path Holdings: Q2 Earnings Insights
  Bio-Path Holdings (NASDAQ:BPTH) reported its Q2 earnings results on Tuesday, August 16, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Earnings Scheduled For August 16, 2022
Companies Reporting Before The Bell • Stronghold Digital Mining (NASDAQ:SDIG) is projected to report earnings for its second quarter. 
Via Benzinga
Earnings Outlook For Bio-Path Holdings
  Bio-Path Holdings (NASDAQ:BPTH) is set to give its latest quarterly earnings report on Tuesday, 2022-08-16. Here's what investors need to know before the announcement. 
Via Benzinga
10 Biggest Price Target Changes For Thursday
Telsey Advisory Group cut the price target for Bath & Body Works, Inc. (NYSE: BBWI) from $70 to $60. Bath & Body Works shares fell 6.9% to $40.00 in pre-market trading. 
Via Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech's COVID-19 Booster For Kids 5-11 Coming Soon, Ultragenyx In-Licenses Gene Therapy For Genetic Disorder, Ampio's AP-013 Trial Under Independent Investigation
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Bio-Path Holdings: Q1 Earnings Insights
Bio-Path Holdings (NASDAQ:BPTH) reported its Q1 earnings results on Tuesday, May 17, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Earnings Scheduled For May 17, 2022
Companies Reporting Before The Bell • On Holding (NYSE:ONON) is likely to report earnings for its first quarter. 
Via Benzinga
A Preview Of Bio-Path Holdings's Earnings
Bio-Path Holdings (NASDAQ:BPTH) is set to give its latest quarterly earnings report on Tuesday, 2022-05-17. Here's what investors need to know before the announcement. Analysts estimate that Bio-Path... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers 
Via Benzinga
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.